ArticleCanada Legislates The Use Of Inventions During The PandemicUnder Bill C-13, emergency measures will now be available to Canadians and Canadian businesses. CanadaCoronavirus (COVID-19)Norton Rose Fulbright Canada LLP
ArticleCOVID-19: Canadian Government Can Now Use Patented Inventions To Respond To The Public Health EmergencyIn response to the COVID-19 pandemic, the government of Canada quickly gave itself the authority to use and even sell inventions that have been patented by others, to the extent necessary to respond to the public health emergency. CanadaCoronavirus (COVID-19)McCarthy Tétrault
ArticlePatent Issues Under Canada's COVID-19 Emergency Response ActThe Federal Government's COVID-19 Emergency Response Act contains certain amendments to the Patent Act that permit the Federal Government authorize anyone to "make, construct, use and...CanadaCoronavirus (COVID-19)Field Law
ArticleOntario Not-for-Profit Corporations Act – Transition And Next StepsAs we reported last week, the Ontario government announced that, after almost 11 years, the Ontario Not-for-Profit Corporations Act (ONCA) is finally being proclaimed into force effective October 19, 2021 (proclamation date).CanadaCorporate/Commercial LawTorkin Manes LLP
ArticleBLG Guide | Newly Updated And Expanded For 2022The fourth edition of Borden Ladner Gervais LLP's Life Sciences & Chemistry Patent Practice in Canada: A Practical Guide is now available...CanadaFood, Drugs, Healthcare, Life SciencesBorden Ladner Gervais LLP
ArticleCDA Opens Consultation On Proposed List Of Drugs To Inform Development Of National FormularyOn June 19, 2025, Canada's Drug Agency (CDA) opened a public consultation on a proposed process for preparing a list of essential prescription drugs and related products.CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticleCompetition Bureau Closes Two Investigations Into Pharmaceutical Patent Litigation SettlementsOn May 20, 2022, the Competition Bureau announced that it closed two investigations into pharmaceutical patent litigation settlement agreements as evidence gathered...CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
VideoFrom Discovery To Market: The Role Of IP Strategy In Drug Development (Video)Brian Kingwell, a partner, patent agent, and trademark agent in the firm's Vancouver office, has more than two decades of experience in patent prosecution and strategic patent portfolio counselling.CanadaFood, Drugs, Healthcare, Life SciencesGowling WLG
ArticleIntellectual Property Weekly Abstracts Bulletin - Week of June 13, 2011Appeal Allowing Amendments to Pleadings Dismissed. Drug: gemcitabineCanadaFood, Drugs, Healthcare, Life SciencesBorden Ladner Gervais LLP
ArticleIntellectual Property Weekly Abstracts Bulletin - Week of March 12, 2012The Federal Court of Appeal (FCA) upheld a decision of the Motions Judge, which upheld the decision of a Prothonotary, granting leave to the respondents to amend their pleadings. CanadaFood, Drugs, Healthcare, Life SciencesBorden Ladner Gervais LLP
ArticlePMPRB Announces Next Steps In Guidelines Consultation ProcessAs we reported, the Patented Medicine Prices Review Board (PMPRB) adopted its Amended Interim Guidance on September 27, 2023. The Interim Guidance provides information on how the PMPRB...CanadaFood, Drugs, Healthcare, Life SciencesCassels
ArticlePMPRB Interim Guidance UpdatedOn August 18, 2022, PMPRB announced its Decision resulting from the consultation on the PMPRB Price Review Approach During the Interim Period following publication of Amendments to the Patented Medicines Regulation...CanadaFood, Drugs, Healthcare, Life SciencesFasken
ArticleSupreme Court Of Canada Dismisses First Section 8 Damages AppealOn April 20, 2015, the Supreme Court of Canada dismissed Sanofi-Aventis’ appeal concerning a claim by Apotex for section 8 damages under the Patented Medicines (Notice of Compliance) Regulations. CanadaFood, Drugs, Healthcare, Life SciencesGowling WLG
ArticleA Sale In Canada Triggers Exhaustion Of Patent Rights In The US"Patent exhaustion" is something we've reviewed before. To recycle an old line, the term "patent exhaustion" does not refer to the feeling you get when a patent agent talks for 3 hours ...CanadaIntellectual PropertyField Law
ArticleAbuse Of Process Clarified By Canadian Federal Court Of AppealIn a recent decision, Apotex Inc. v. Janssen-Ortho Inc, the Federal Court of Appeal has limited the scope of the abuse of process doctrine in applications under the Patented Medicines (Notice of Compliance) Regulations. CanadaIntellectual PropertyTorys
ArticleAccelerated Patent Examination Now Available For Critical Mineral Technologies In CanadaCanada's Intellectual Property Office has introduced a new expedited examination program for patent applications in critical technology areas, including a dedicated stream for innovations related to the processing, extraction, and refining of minerals on Canada's critical minerals list. The program offers accelerated patent examination on a first-come, first-served basis with specific eligibility requirements and annual application limits. CanadaIntellectual PropertyGowling WLG
ArticleAlberta Court Of Appeal Clarifies Limitation Period For Patent Infringement ClaimsThe Alberta Court of Appeal has clarified the applicable limitation period for patent infringement claims commenced in Alberta courts in its recent decision...CanadaIntellectual PropertyOyen Wiggs Green & Mutala
ArticleAmendments To Canadian Patent Examination Rules Come Into Force October 3, 2022Canada's federal government has registered certain amendments to Canada's Patent Rules pertaining to examination as final.CanadaIntellectual PropertyTorys
ArticleAmendments To The Patent Rules Coming Into Force October 3, 2022Rules amending the Canadian Patent Rules were recently registered on June 2, 2022. The amendments will largely come into force on October 3, 2022.CanadaIntellectual PropertyOyen Wiggs Green & Mutala
ArticleApotex Not Permitted To Plead Promise-Based Invalidity Grounds In Ontario Section 8 Lansoprazole ActionThis motion arose in the context of a section 8 action in which Apotex claims damages for delay in the issuance of its notice of compliance for its generic lansoprazole product ...CanadaIntellectual PropertySmart & Biggar